JABIL INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data JABIL INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	18,353	19,063	22,095	25,282	27,266	29,285	33,478	34,702	28,883	29,802
Cost of revenue	16,825	17,517	20,389	23,369	25,335	26,926	30,846	31,835	26,207	27,156
Gross profit	1,528	1,546	1,707	1,913	1,931	2,359	2,632	2,867	2,676	2,646
Research and development	32	29.7	38.5	43	43	34	33	34	39	26
Selling, general and administrative	924	908	1,051	1,111	1,175	1,213	1,154	1,206	1,160	1,122
Operating income	523	410	542	701	500	1,055	1,393	1,537	2,013	1,182
Interest expense	137	138	149	188	174	130	151
Interest income	9.13	12.5	17.8	21	15	6	5
Other non-operating income	-8.38	-28.4	-37.6	-53	-31	11	-12	-69	-89	-97
Pre-tax income	387	256	373	451	261	944	1,231	1,262	1,751	892
Income tax	132	129	286	162	204	246	235	444	363	235
Income from continuing operations	254
Net income to minority interests	0.8	-1.92	1.21	2	3	2	0	0	0	0
Net income	254	129	86.3	287	54	696	996	818	1,388	657
EBITDA	1,220	1,171	1,316	1,473	1,295	1,931	2,318	2,461	2,709	1,856
EPS, basic	1.33	0.71	0.50	1.85	0.36	4.69	7.06	6.15	11.34	6.00
EPS, diluted	1.32	0.69	0.49	1.81	0.35	4.58	6.90	6.02	11.17	5.92
Shares, basic (weighted)	190	182	172	156	152	149	141	133	122	110
Shares, diluted (weighted)	193	186	175	159	155	152	144	136	124	111
Dividend per share	0.32	0.32	0.32

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	912	1,190	1,258	1,163	1,394	1,567	1,478	1,804	2,201	1,933
Receivables						3,141	3,995	3,647
Inventory	2,457	2,942	3,458	3,023	3,132	4,414	6,128	5,206	4,276	4,681
Other current assets	1,120	1,097	1,141	502	656	757	1,111	1,109	1,710	2,010
Total current assets	5,848	6,627	7,550	8,345	9,135	10,877	13,908	14,730	12,791	13,720
Property, plant and equipment	3,332	3,229	3,198	3,334	3,665	4,075	3,954	3,137	3,024	2,847
Lease right-of-use assets					363	390	500	367	360	462
Goodwill	595	608	628	622	697	715	704	621	661	841
Intangible assets	297	285	279	257	210	182	158	142	143	273
Other non-current assets	102	142	173	214	162	239	294	268	276	259
Total assets	10,323	11,096	12,046	12,970	14,397	16,654	19,717	19,424	17,351	18,543
Accounts payable	3,593	4,258	4,943	5,167	5,687	6,841	8,006	5,679	6,190	7,937
Accrued liabilities	1,929	2,169	2,263	2,990	3,211	3,734	5,272	5,515	5,499	5,185
Deferred revenue		1,017	0	511	496	559	796	886	1,017	1,016
Short-term debt	45.8	445	25.2	375	50	0	300	0	0	499
Total current liabilities	5,568	6,871	7,231	8,532	9,059	10,683	13,697	12,695	11,782	13,714
Long-term debt	2,074	1,606	2,494	2,121	2,678	2,878	2,575	2,875	2,880	2,386
Lease liabilities					302	333	417	269	284	388
Other non-current liabilities	78	101	94.6	164	269	334	272	319	416	345
Total liabilities	7,865	8,728	10,082	11,070	12,572	14,517	17,265	16,557	15,614	17,026
Total debt	2,074	2,050	2,519	2,496	2,728	2,878	2,875	2,875	2,880	2,885
Paid-in capital	2,035	2,104	2,219	2,305	2,414	2,533	2,655	2,795	2,841	3,047
Retained earnings	1,661	1,731	1,760	2,037	2,041	2,688	3,638	4,412	5,760	6,382
Treasury stock	-1,218	-1,536	-2,009	-2,372	-2,610	-3,060	-3,800	-4,324	-6,818	-7,899
Other comprehensive income	-39.9	54.6	-19.4	-82.8	-34	-25	-42	-17	-46	-17
Shareholders' equity	2,438	2,354	1,950	1,887	1,811	2,136	2,451	2,866	1,737	1,513
Minority interests	19.3	14.8	13.1	13.3	14	1	1	1	0	4
Total equity	2,457	2,368	1,962	1,900	1,825	2,137	2,452	2,867	1,737	1,517
Total liabilities and equity	10,323	11,096	12,046	12,970	14,397	16,654	19,717	19,424	17,351	18,543
Shares outstanding	187	178	165	154	150	144	135	131	114	107

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	255	127	87.5	289	57	698	996	818	1,388	657
Depreciation and amortization	697	760	774	772	795	876	925	924	696	674
Stock-based compensation	59	48.5	98.5	61	83	102	81	95	89	107
Deferred income tax	-24.1	-62.3	37.9	8	26	-16	-13	91	-84	-120
Change in receivables	122	-2,828	-2,334	-587	-136	-283	-878	267	-200	-504
Change in inventory	68	-445	-499	483	-77	-1,276	-1,725	370	1,179	-431
Change in payables	-86.1	744	815	962	593	1,310	2,866	-853	106	1,426
Cash from operations	916	-1,464	-1,105	1,193	1,257	1,433	1,651	1,734	1,716	1,640
Capital expenditures	-924	-716	-1,037	-1,005	-983	-1,159	-1,385	-1,030	-784	-468
Acquisitions	-242	-36.6	-110	-153	-147	-50	-18	-29	-90	-392
Cash from investing	-1,180	2,141	1,241	-872	-921	-851	-858	-723	1,351	-714
Share buybacks	-148	-307	-450	-350	-215	-428	-696	-487	-2,500	-1,000
Dividends paid	-62.4	-60	-57.8	-52	-50	-50	-48	-45	-42	-36
Cash from financing	254	-405	-47	-416	-65	-413	-888	-680	-2,668	-1,204
Exchange rate effect	8.36	5.23	-20.4	0	-40	4	6	-5	-2	10
Net change in cash	-1.9	278	68	-95	231	173	-89	326	397	-268
Free cash flow	-8.03	-2,181	-2,142	188	274	274	266	704	932	1,172
Interest paid	128	131	167	186	183	124	150	211	167	162
Income taxes paid	141	188	180	168	164	211	209	319	502	330

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $316.74 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	9.2%	Gross profit / revenue.
Operating margin	4.3%	Operating income / revenue.
EBITDA margin	6.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.5%	Pre-tax income / revenue.
Net margin	2.6%	Net income / revenue.
FCF margin	3.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.5%	Cash from operations / revenue.
Effective tax rate	26.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	65.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.6%	Net income / average total assets.
Return on invested capital (ROIC)	31.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	0.1%	Research and development expense / revenue.
SG&A / revenue	3.9%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.6%	Capital expenditures / revenue.
D&A / revenue	2.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-3.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-1.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	0.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-41.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-5.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	18.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-31.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-7.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	7.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-52.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-13.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	64.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-47.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-5.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	76.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-4.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-0.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	5.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	25.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	63.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	33.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-12.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-14.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-3.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	6.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-2.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-10.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-8.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-6.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.98x	Current assets / current liabilities.
Quick ratio	0.07x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.07x	(Cash + short-term investments) / current liabilities.
Debt / equity	2.55x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	14.2%	Total debt / total assets.
Liabilities / assets	94.4%	Total liabilities / total assets.
Net debt	$2.02B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.94x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	-$353.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	7.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$532.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.41x	Revenue / average total assets.
Fixed asset turnover	11.6x	Revenue / average property, plant and equipment.
Inventory turnover	5.14x	Cost of revenue / average inventory.
Days inventory	71 days	365 x average inventory / cost of revenue.
Days payables	143 days	365 x average accounts payable / cost of revenue.
FCF conversion	151.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	29.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$8.09	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$315.40	Revenue / diluted weighted shares.
FCF per share	$12.26	Free cash flow / diluted weighted shares.
Operating cash flow per share	$17.44	Cash from operations / diluted weighted shares.
Book value per share	$12.62	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$5.08	Tangible book value / shares outstanding.
Cash per share	$12.97	(Cash + short-term investments) / shares outstanding.
Payout ratio	4.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	2.7%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	70.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$33.19B	Share price x shares outstanding.
Enterprise value	$35.21B	Market cap + total debt - cash - short-term investments.
P/E	38.5x	Market cap / net income. Only when net income is positive.
P/S	0.99x	Market cap / revenue.
P/B	25.1x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	25.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	17.9x	Market cap / cash from operations, when positive.
EV/Sales	1.05x	Enterprise value / revenue.
EV/EBIT	24.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	16.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	27.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.9%	Free cash flow / market cap.
Earnings yield	2.6%	Net income / market cap (the inverse of P/E).
Dividend yield	0.1%	Dividends paid over the period / market cap.
Shareholder yield	2.9%	(Dividends paid + share buybacks) / market cap.

What was JABIL INC's revenue in fiscal 2025?

JABIL INC reported revenue of $29.80B for fiscal 2025, 3.2% higher than the year before.

Was JABIL INC profitable in fiscal 2025?

Yes. Net income was $657.0M, a net margin of 2.2%.

How much free cash flow did JABIL INC generate in fiscal 2025?

Cash from operations of $1.64B minus capital expenditures of $468.0M left free cash flow of $1.17B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to JABIL INC